ArticleFrontiers in oncology2022

Clinical N3 is an independent risk factor of recurrence for breast cancer patients achieving pathological complete response and near-pathological complete response after neoadjuvant chemotherapy.

Xiaoyan Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.